is rybelsus a glp-1 drug Novo's gains FDA expansion to reduce risk of MACE Orforglipron: new GLP-1 pill beats

This article explores the science behind these agents.

Rationale Obesity remains a major global health challenge, severely affecting metabolic and cardiovascular health

Feel lighter and more in control of your life

This shift from "Large Molecule/Biologic" to "Small Molecule/Chemical" changes everything: Easier Synthesis: They are produced via standard chemical synthesis rather than complex biological fermentation or solid-phase peptide synthesis (SPPS)

Not a fit for compounded GLP-1? You may still qualify for our Microdosing program, a lower dose option designed for patients outside the standard BMI range

Grading of Recommendations Assessment, Development and Evaluation (GRADE) showed moderate certainty for MACE, all-cause death and hospitalization for HF